Firstly, we used the Oncomine database to confirm GSTMs mRNA level in multiple cancer types compared to the corresponding para-carcinoma samples (Figure 2), which showed that GSTM1/2/3/4/5 were significantly decreased in many cancers, especially in OC. This evidence concerns the gene GSTM1 and cancer.